BioAdvance NewsBobcatBioPortfolio News

SIRPant Immunotherapeutics (now BobcatBio) Appoints Jelle Kijlstra, MD, MBA as Chief Medical Officer

By July 11, 2023March 18th, 2026No Comments

SIRPant Immunotherapeutics (now BobcatBio) Appoints Jelle Kijlstra, MD, MBA as Chief Medical Officer

Accomplished healthcare executive brings extensive drug development and regulatory experience from global CRO and multiple pharmaceutical companies to SIRPant Immunotherapeutics Inc

See more here